Financial Performance
- Revenue from operations for Apr-Jun FY27: ₹99.60 crore (INR 9,960.22 lakhs)
- Achieved nearly 50% of previous financial year's full-year revenue in first quarter
- Improved margins compared to previous periods
Subsidiary Update - Vinstar Biotech Private Limited
- Received trial orders from multiple customers for value-added ingredients developed in-house
- Order sizes described as modest but significant for validating R&D capabilities
- Marks group's first steps as developer of proprietary formulations rather than just ingredient supplier
Manufacturing Facility Progress - Easy Raw Materials Private Limited
- Manufacturing facility development progressing on schedule within planned timeline
- Civil work progressing as per plan
- Electricity sanction letter received for power infrastructure
- Packaging machinery finalized, with delivery expected within 30-35 days of PO release
- Company committed to communicate any delays in project schedule to stakeholders
Business Development
- Added 20 new customers during Apr-Jun FY27
- 15 R&D projects in pipeline
- Participated in three key industry exhibitions across India and Europe in first half of 2026
- Celebrated Nutrition Day and Yoga Day internally
Strategic Direction
Company is transitioning from product supplier to solutions partner by:
- Investing in Research & Development
- Providing complete customized solutions including ingredient selection, application support, formulation guidance
- Building scalable processes aligned with manufacturing integration
- Improving sourcing efficiency and turnaround timelines
Expansion Plans
Strategic expansion into functional and value-added ingredient categories including:
- Proteins
- Functional fibers
- Salt reduction solutions
Market Outlook
- Global nutraceutical industry showing strong upward trajectory
- Asia-Pacific dominating global demand and supply dynamics
- Key trends: preventive healthcare, functional ingredients, science-backed formulations, supply chain diversification
- Industry moving from volume-driven to value-driven, science-backed ecosystems
Forward-looking Statements
- Commissioning of EZRM manufacturing facility with sequenced machine deliveries
- Scaling R&D investment and customized solutions offering
- Strengthening global sourcing footprint and long-term supplier partnerships
- Sustaining strong revenue growth through consistent CAGR-driven execution
Investor Relations Contacts
- Rasika Sawant: rasika@x-b4.com, +91-9594457518
- Aagam Shah: aagam@x-b4.com, +91-8850166932
Disclaimer
This update is for information purposes only and does not constitute an offer or recommendation to purchase securities. Contains forward-looking statements subject to risks and uncertainties. Figures are unaudited unless otherwise stated.